Sarkunam Kandhasamy

发表

Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection.

A. Mathur, N. Meanwell, Chaoqun Chen, 2020, Journal of medicinal chemistry.

Boron: A key element in radical reactions

B. Becattini, P. Renaud, E. Scanlan, 2007 .

Discovery of BMS-986339, a Pharmacologically Differentiated Farnesoid X Receptor Agonist for the Treatment of Nonalcoholic Steatohepatitis.

S. E. Kiefer, J. Krupinski, Srinivas Cheruku, 2022, Journal of medicinal chemistry.